GB1145437A - Nitro-estratrienes - Google Patents

Nitro-estratrienes

Info

Publication number
GB1145437A
GB1145437A GB51714/67A GB5171467A GB1145437A GB 1145437 A GB1145437 A GB 1145437A GB 51714/67 A GB51714/67 A GB 51714/67A GB 5171467 A GB5171467 A GB 5171467A GB 1145437 A GB1145437 A GB 1145437A
Authority
GB
United Kingdom
Prior art keywords
formula
hydrogen
nov
compound
estratrienes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB51714/67A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmaceutici Italia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia SpA filed Critical Farmaceutici Italia SpA
Publication of GB1145437A publication Critical patent/GB1145437A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Manufacture And Refinement Of Metals (AREA)
GB51714/67A 1966-11-18 1967-11-14 Nitro-estratrienes Expired GB1145437A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT3007766 1966-11-18

Publications (1)

Publication Number Publication Date
GB1145437A true GB1145437A (en) 1969-03-12

Family

ID=11228982

Family Applications (1)

Application Number Title Priority Date Filing Date
GB51714/67A Expired GB1145437A (en) 1966-11-18 1967-11-14 Nitro-estratrienes

Country Status (15)

Country Link
US (1) US3520909A (enExample)
AT (1) AT271757B (enExample)
BE (1) BE706686A (enExample)
CH (1) CH493506A (enExample)
DE (1) DE1618977B1 (enExample)
DK (1) DK116659B (enExample)
ES (1) ES347318A1 (enExample)
FR (1) FR7064M (enExample)
GB (1) GB1145437A (enExample)
GR (1) GR38947B (enExample)
IL (1) IL28936A (enExample)
NL (2) NL6715106A (enExample)
NO (1) NO128023B (enExample)
SE (1) SE335527B (enExample)
YU (1) YU31806B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554603A (en) * 1993-09-17 1996-09-10 The United States Of America As Represented By The Department Of Health And Human Services Orally active derivatives of 1,3,5(10)-estratriene

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554603A (en) * 1993-09-17 1996-09-10 The United States Of America As Represented By The Department Of Health And Human Services Orally active derivatives of 1,3,5(10)-estratriene

Also Published As

Publication number Publication date
YU222567A (en) 1973-06-30
DE1618977B1 (de) 1972-07-20
US3520909A (en) 1970-07-21
CH493506A (de) 1970-07-15
AT271757B (de) 1969-06-10
GR38947B (el) 1970-01-20
NL6715106A (enExample) 1968-05-20
ES347318A1 (es) 1969-02-01
NL135316C (enExample)
NO128023B (enExample) 1973-09-17
DK116659B (da) 1970-02-02
YU31806B (en) 1973-12-31
BE706686A (enExample) 1968-05-17
FR7064M (enExample) 1969-06-23
IL28936A (en) 1972-07-26
SE335527B (enExample) 1971-06-01

Similar Documents

Publication Publication Date Title
GB1246006A (en) Pyrazine derivatives and their conversion to imidazopyrazines
GB1153982A (en) New Sulphonylurea Derivatives and Process for preparing them
GB1054104A (enExample)
GB1204922A (en) 03-alkyl-9,10-seco-gonatetraenes and processes for their preparation
ES400452A1 (es) Procedimiento para la obtencion de un medio para regular el crecimiento de las plantas a base de acidos 2-halogenoe- tano sulfinicos.
GB1075251A (en) Cardenolide derivatives
ES347318A1 (es) Procedimiento para la preparacion de nuevos nitro-estra- trienos.
JPS5227753A (en) Prostaglandin analogues, their preparation, and pharmaceutical composi tions containing the same as active ingredient
GB1415601A (en) Dihydrobetulinic acid derivatives
GB1187660A (en) Fluoroformates of Steroid 17-beta-Ols
GB1141214A (en) New derivatives of proscillaridin a
GB1398058A (en) 1,1-hexamethylene-bisguanidino compounds
GB1513724A (en) Derivatives of thiocolchicine
SE332172B (enExample)
GB1434378A (en) Cyano-pregnene compounds
GB1289956A (enExample)
ES347230A1 (es) Procedimiento para preparar carbonatos de 3-oxo - 17-beta- hidroxiestra-4, 9, 11-trieno.
GB1455396A (en) 4,-o-sulphonyl-erythromycin-9-o-oxime derivatives
GB1310779A (en) N-pyridylalkyl-beta-alkoxy-beta-trifluoromethylphenalkylamines
GB985004A (en) 6-methyl-ergoline i derivatives
GB1472344A (en) Methylene dibenzocycloheptanes
GB1169134A (en) Cyano-Steroids
CA843404A (en) Anesthetic compositions containing derivatives of 10,11-dihydro-5h-dibenzo(a,d)cycloheptene
ES292175A1 (es) Método de preparación de 1,2-dimetilexahidropirilazinas análogos endometilénicos de las mismas y sales de adición farmacéuticamente aceptables
GB1316920A (en) Epoxy compounds